Lisa M. Blair

Lisa M. Blair

Auto-generated profile, based on publicly available information

Lisa M. Blair

College of Nursing, Wayne State University, Detroit, MI, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in SLEEP
Verified
Journal Article
Closed access
LBLisa M. Blair
Lisa M. Blair
KPKyle Porter
Kyle Porter
BLBinnaz Leblebicioglu
Binnaz Leblebicioglu
LCLisa M. Christian
Lisa M. Christian
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

9 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LCLisa M. Christian
Lisa M. Christian
LBLisa M. Blair
Lisa M. Blair
KPKyle Porter
Kyle Porter
MLMary Lower
Mary Lower
RCRachel M. Cole
Rachel M. Cole
MBMartha A. Belury
Martha A. Belury
Mechanistic pathways linking maternal polyunsaturated fatty acid (PUFA) status with gestational length are poorly delineated. This study examined whether inflammation and sleep quality serve as mediators, focusing on the antiinflammatory ω-3 docosahexaenoic acid (DHA; 22:6n3) and proinflammatory ω-6 arachidonic acid (AA; 20:4n6). Pregnant women (n = 135) provided a blood sample and completed the Pittsburgh Sleep Quality Index (PSQI) at 20–27 weeks gestation. Red blood cell (RBC) fatty acid levels were determined by gas chromatography and serum inflammatory markers [interleukin (IL)-6, IL-8, tumor necrosis factor-α, IL-1β, and C-reactive protein] by electrochemiluminescence using high sensitivity kits. Both higher serum IL-8 (95% CI = 0.10,3.84) and poor sleep (95% CI = 0.03,0.28) served as significant mediators linking lower DHA:AA ratios with shorter gestation. Further, a serial mediation model moving from the DHA:AA ratio → sleep → IL-8 → length of gestation was statistically significant (95% CI = 0.02, 0.79). These relationships remained after adjusting for depressive symptoms, age, BMI, income, race, and smoking. No interactions with race were observed in relation to length of gestation as a continuous variable. However, a significant interaction between race and the DHA:AA ratio in predicting preterm birth was observed (p = 0.049); among African Americans only, odds of preterm birth decreased as DHA:AA increased (p = 0.048). These data support a role for both inflammatory pathways and sleep quality in linking less optimal RBC PUFA status with shorter gestation in African American and European American women and suggest that African-Americans have greater risk for preterm birth in the context of a low DHA:AA ratio.

15 September 2015 in Biological Research For Nursing
Verified
Journal Article
Closed access
PDF file
LBLisa M. Blair
Lisa M. Blair
RPRita H. Pickler
Rita H. Pickler
CACindy Anderson
Cindy Anderson
Preterm infants are at elevated risk for a host of neurodevelopmental problems, including disorders that appear later in life. Gene–environment interactions and prematurity may combine to increase the risk for poor neurodevelopmental outcomes. Increasing evidence supports a genetic link to risk for atypical development; however, no genomic risk profiles are currently used for infants without apparent genetic disorders. The purpose of this review was to synthesize recent evidence of genetic associations with atypical neurodevelopmental outcomes that may affect preterm infants who do not have a rare genetic disease. Electronic and hand-search strategies were used to find relevant articles that were English-language, peer-reviewed primary research or meta-analysis reports published between July 2009 and July 2014, involving human participants. Articles included in the analysis (N = 29) used a wide range of study designs and methodologies, complicating the analysis. An integrative-review design was used to synthesize the data. Numerous genes (n = 43) and additional large deletion copy number variants were associated with neurodevelopmental outcomes, including cognition, attention, perception, psychiatric disease, autism spectrum disorder, cerebral palsy, infant behavior, and alterations in brain architecture. The creation of genetic risk profiles for complex disorders of neurodevelopment is presently hindered by inconsistent genetic-association evidence, methodological considerations, reporting problems, and lack of replication. However, several avenues of investigation offer promise, including large (>100 kb) copy number variants and the candidate genes MET, NRG3, and SLC6A4, each of which were reported to have associations with neurodevelopmental outcomes in multiple, high-quality studies.

26 January 2025 in Addictive Behaviors Reports
Verified
Journal Article
Open access
MSMarvin A. Schilt-Solberg
Marvin A. Schilt-Solberg
LBLisa M. Blair
Lisa M. Blair
JKJulie A.M.J. Kurzer
Julie A.M.J. Kurzer
This study examines the impact of the intersection of gender, racial/ethnic identity, and sexual orientation among adults on substance use disorders (SUDs) from 2021 to 2022. We conducted an analysis of persons (ages 18 and older) who responded to the 2021 and 2022 National Survey on Drug Use and Health (NSDUH). Logistic regression models were constructed to examine odds of past-year SUDs at the intersection of gender, sexuality, and race/ethnicity. All analyses were design-corrected to enhance population representativeness and generalizability. Prevalence varied by race/ethnicity and sexual orientation across both sexes (total n = 83,722). Non-Hispanic multiracial lesbian/gay individuals had the highest prevalence of any SUD in both sexes (46.6 % in women, 52.3 % in men). Bisexual women showed consistently elevated odds of SUD across most racial/ethnic groups (aORs 1.48–2.99) compared to White heterosexual women. Men had higher prevalence of SUD than women (21.1 % compared to 15.0 %, p < 0.0001). Only White gay and bisexual men had significantly increased odds for any SUD compared to heterosexual White men (aOR 1.73 and 1.57, respectively). White bisexual men had higher odds of reporting cannabis use disorder (CUD; aOR 1.87). Hispanic men demonstrated lower odds of any SUD or CUD (aORs 0.85 and 0.71, respectively). Women demonstrated more pronounced SUD disparities between intersectional identity. While men had higher SUD prevalence overall, few disparities were observed between intersectional identities. To effectively address these disparities and their consequences (e.g., differential minority stress and mental/physical health outcomes), prevention and intervention efforts should prioritize an intersectionality approach.

1 October 2021 in Journal of Perinatal & Neonatal Nursing
Verified
Journal Article
Closed access
LBLisa M. Blair
Lisa M. Blair
KAKristin PhD Ashford
Kristin PhD Ashford
LGLauren Bs Gentry
Lauren Bs Gentry
SBSarah Bell
Sarah Bell
AFAmanda Fallin-Bennett
Amanda Fallin-Bennett
Opioid use in the perinatal period has escalated rapidly, with potentially devastating outcomes for perinatal persons and infants. Substance use treatment is effective and has the potential to greatly improve clinical outcomes; however, characteristics of care received from providers including nurses have been described as a barrier to treatment. Our purpose was to describe supportive perinatal care experiences of persons with opioid use disorder. A qualitative descriptive study design was used to examine experiences of 11 postpartum persons (ages 22-36 years) in medication-assisted treatment for opioid use disorder at an academic medical center in the southern region of the United States. Participants were interviewed about experiences with perinatal and neonatal care during the child's hospitalization for neonatal abstinence syndrome surveillance and/or treatment. Four themes of supportive care experiences emerged: informing, relating, accepting, and holistic supporting. Participants reported a range of positive and negative perinatal care experiences, with examples and counterexamples provided. This fuller understanding of perceptions and lived experiences of care can inform practice changes and educational/training priorities. Future research is needed to facilitate development of comprehensive care models geared to address perinatal care needs of persons with opioid use disorder.

17 June 2019 in Maternal and Child Health Journal
Verified
Journal Article
Closed access
PDF file
LBLisa M. Blair
Lisa M. Blair
JFJodi L. Ford
Jodi L. Ford